Doctor Cho-Kai Wu

National Taiwan University Hospital, Taipei (Taiwan)

Contributor content

Presentation

Effects of atorvastatin treatment on left ventricular diastolic function in peritoneal dialysis patients - the ALEVENT randomized clinical trial

Presentation

Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices

Presentation

Fetuin-A expression and cardiac fibrosis in diastolic heart failure using nephrectomy animal model and clinical cardiac magnetic resonance imaging

Presentation

Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nation-wide data survey and propensity analysis

$Differential association of plasma biomarkers with myocardial fibrosis or heart failure symptoms in heart failure with preserved ejection fraction patients$

Presentation

Differential association of plasma biomarkers with myocardial fibrosis or heart failure symptoms in heart failure with preserved ejection fraction patients

Explore sponsored resources

Doctor Cho-Kai Wu

Contributor content

Effects of atorvastatin treatment on left ventricular diastolic function in peritoneal dialysis patients - the ALEVENT randomized clinical trial

Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices

Fetuin-A expression and cardiac fibrosis in diastolic heart failure using nephrectomy animal model and clinical cardiac magnetic resonance imaging

Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nation-wide data survey and propensity analysis

Differential association of plasma biomarkers with myocardial fibrosis or heart failure symptoms in heart failure with preserved ejection fraction patients

ESC 365 is supported by